Keywords: bbc, documents, regen, zolpidem, study, use, uk

BBC documents ReGen's zolpidem study

Article | 21 November 2007

Print This

Use of UK biotechnology firm ReGen Therapeutics' novel zolpidem formulation as a treatment for the dormancy associated with brain damage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in